Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Resolved 2018-10-22 2020-06-11 65343
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
ACT OLOPATADINE 0.1% 0.1% SOLUTION Actual shortage 2018-10-23 2018-10-23 65519

Showing 181 to 200 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818

Showing 61 to 80 of 300